Tech Company Financing Transactions
Pulmotect Funding Round
Pulmotect secured a $1.8 million Series A funding round on 5/9/2016. Backers included private investors.
Transaction Overview
Company Name
Announced On
5/9/2016
Transaction Type
Venture Equity
Amount
$1,751,430
Round
Series A
Investors
Proceeds Purpose
Proceeds purposes were not disclosed. 5 investors participated in the offering. The amount may include options, warrants or other securities. Contact technology company for investment details, if applicable. Not an offer or solicitation for the sale of securities or debt. SEC regulatory filing.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
3900 Essex Ln. 575
Houston, TX 77027
USA
Houston, TX 77027
USA
Phone
Website
Email Address
Overview
Pulmotect, Inc. is a Houston-based biotechnology company, developing products that boost the innate immune system to protect against a wide range of lung infections. Our cofounders are leaders in the emerging science of innate immunity in the lungs.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Colin Broom
Chief Medical Officer
Anoshie Ratnayake
Chief Medical Officer
Atul Varadhachary
President
Brenton Scott
Browse more venture capital transactions:
Prev: 5/9/2016: MIODx venture capital transaction
Next: 5/9/2016: Relayware venture capital transaction
Share this article
News on VC Transactions
We report on all VC transactions involving tech companies. VC investment data records reported here are sourced from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs